Redwood Scientific Technologies logo

Redwood Scientific Technologies(OTC) RSCI

Market Cap$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)-100%
5 Year-100%
1 Year-100%
1 Month-99%
$0.00
+0.00%
+0.00Today
Redwood Scientific Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-30
Redwood Scientific Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-99%USD 0.002026-08-28
1 month-99%USD 0.002026-08-28
3 month-99.99%USD 0.012026-07-02
Year to date-99.99%USD 0.012025-12-23
1 year-100%USD 0.072025-07-17
3 year-100%USD 0.372023-09-26
5 year-99.99%USD 0.012021-09-27
Since inception-100%USD 10,134.632009-10-22

Redwood Scientific Technologies Financials at a Glance

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$3.42M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.02 (Low)

Price

$0.00

Volume

108

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.07

Estimated Earnings Date

N/A

RSCI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Redwood Scientific Technologies

Redwood Scientific Technologies, Inc. specializes in developing and marketing over-the-counter FDA registered drugs utilizing innovative oral strip delivery technology. Based in Claremont, California, the company operates within the medical and pharmaceutical industry, focusing on enhancing consumer access to effective healthcare solutions.

Products and Services
  • Over-the-counter FDA registered drugs
  • Oral strip delivery technology for easy consumption
  • Innovative healthcare solutions targeting consumer needs
Growth Outlook
  • Recent quarterly expenses indicate a focus on marketing and operational efficiency
  • Cash reserves of $271,471 as of Q4 2023 support ongoing operations
  • Potential for market expansion in the healthcare sector with innovative products
Financial Highlights
  • Net income of -$2,494,666 reported in Q4 2023
  • Cash flow from operations shows a decrease, indicating financial challenges
  • Current liabilities increased to $491,077 in Q4 2023
Redwood Scientific Technologies, Inc. is positioned in a competitive healthcare market, focusing on innovative drug delivery methods. The company has faced financial challenges, as indicated by recent net income losses and increasing liabilities. However, the cash reserves provide a buffer for ongoing operations and potential growth initiatives. The focus on marketing and operational efficiency may enhance the company's ability to capture market share in the evolving healthcare landscape. Investors may find interest in the company's innovative approach to drug delivery and its potential for future growth.
AI Generated • Sep 17, 2026

Industry

Personal Products

Sector

Consumer Staples

CEO

Jason Cardiff

Website

www.redwoodsci.co

Headquarters

Claremont, CA 91711, US

RSCI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

2058.35%

Return on Capital

N/A

Return on Assets

-1174.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

204.94M

Volume

108

Avg. Volume

26

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$3.42M

EBITDA

-$3.42M

Operating Cash Flow

-$1.07M

Capital Expenditure

$4.00

Free Cash Flow

-$1.07M

Cash & ST Invst.

$271.47K

Total Debt

$0.00

Redwood Scientific Technologies Performance Analysis

Redwood Scientific Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
Redwood Scientific Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-31N/A
Q22023-06-30N/A
Q32023-09-30N/A
Q42023-12-31N/A
Redwood Scientific Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.00N/A
20222022-12-31USD -0.00N/A
20232023-12-31USD -0.022150.0%
Redwood Scientific Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-31-37.5%
Q22023-06-30-27.3%
Q32023-09-30-64.3%
Q42023-12-31-430.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$40.00

N/A

Employees

5

N/A

Net Income

-$2.49M

-1635.9%

EBITDA

-$2.49M

-1635.9%

Quarterly Fundamentals

Name
Q4 2023YOY CHG

Total Cash

$271.47K

+95.9%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-11.74%

N/A

Return on Invested Capital

17.89%

N/A

Free Cash Flow

-$352.94K

N/A

Operating Cash Flow

-$352.94K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ISHIIslet Holdings, Inc.
$0.00+0.00%
ETAOFEtao International Co., Ltd.
$0.00+0.00%
TBETTibet Pharmaceuticals, Inc.
$0.00+0.00%
THMOThermoGenesis Holdings, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.14-9.97%
VEEAVeea
$6.19+59.95%
WFFWf
$4.03+96.54%
SPCXSpace Exploration Technologies
$162.08+0.94%

Questions About RSCI

What is the current price of Redwood Scientific Technologies?

Redwood Scientific Technologies is trading at $0.00 per share.

What is the 52-week range for Redwood Scientific Technologies?

Over the past 52 weeks, Redwood Scientific Technologies has traded between $0.00 and $0.07.

How much debt does Redwood Scientific Technologies have?

As of the most recent reporting period, Redwood Scientific Technologies reported total debt of $0.00.

How much cash does Redwood Scientific Technologies have on hand?

Redwood Scientific Technologies reported $271.47K in cash and cash equivalents in its most recent financial results.

What is Redwood Scientific Technologies’s dividend yield?

Redwood Scientific Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services